Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
INDUSTRY
×
capmatinib
×
Clear all
Filters
3
NCT04427072
2025-05-16
GeoMETry-III
Novartis
Phase 3
Terminated
22 enrolled
22 charts
NCT04816214
2024-03-05
GEOMETRY-E
Novartis
Phase 3
Terminated
6 enrolled
20 charts